Literature DB >> 33606606

Prevalence and factors associated with hepatitis B virus infection among household members: a cross-sectional study in Beijing.

Xuan Zhao1, Xuefeng Shi2, Min Lv3, Beibei Yuan1, Jiang Wu3.   

Abstract

HBV prevention and control presents a global public health priority because of the tremendous economic and healthcare burdens involved. This study was designed to investigate the status of HBV epidemics among household members, and to analyze the risk factors of HBV infection in couples and their offspring. A total of 1,035 couples and 541 offspring were included. We sourced the data from a population-based serological survey conducted by the Beijing Center for Disease Prevention and Control in 2014. Chi-square test and multiple logistic were used to assess differences in the prevalence of categorical variables, and identify risk factors for HBV infection and exposure in couples and offspring after controlling for confounding factors. In couples, the prevalence of chronic HBV infection was 4.3% and the prevalence of exposure 32.7%. The prevalence of chronic HBV infection in offspring was 0.9%, and the prevalence of exposure 8.7%. Sharing syringes with others and living with a spouse who was infected or exposed to HBV were associated with a significantly higher risk for transmission of HBV for couples. In offspring, maternal HBV infection was a significant risk factor for HBV exposure. This study provides evidence that having household members infected or exposed to HBV increases the risk of HBV transmission, and in order to achieve better control of HBV infection effective strategies must be established to prevent intra-familial transmission.

Entities:  

Keywords:  Cross-sectional; familial transmission; hepatitis B virus; household members

Mesh:

Substances:

Year:  2021        PMID: 33606606      PMCID: PMC8115595          DOI: 10.1080/21645515.2020.1847951

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  48 in total

1.  Discrimination against people with hepatitis B in China.

Authors:  Quancheng Kan; Jianguo Wen; Rui Xue
Journal:  Lancet       Date:  2015-07-18       Impact factor: 79.321

Review 2.  Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-03-27

3.  Risk factors for hepatitis B and C infection among blood donors in five Chinese blood centers.

Authors:  Yi Huang; Nan Guo; Qilu Yu; Yunlai Lv; Hongli Ma; Zhongqiao Yun; Fuzhu Yao; Xiangdong Dong; Xiangming Zhu; Xiuqiong Wen; Ruan Cao; Mei Huang; Xinhong Bi; Mingjiang Zhao; Mei-hei-li Tiemuer; Julin Li; Zhongmin Zhou; Weilan He; Jing Liu; David J Wright; Jingxing Wang; Paul Ness; Hua Shan
Journal:  Transfusion       Date:  2014-11-10       Impact factor: 3.157

4.  Horizontal transmission of de novo hepatitis B between spouses: A case report.

Authors:  Seiichi Mawatari; Hirofumi Uto; Akihiro Moriuchi; Kazuaki Tabu; Kaori Muromachi; Eriko Tabu; Kohei Oda; Dai Imanaka; Akihiko Oshige; Junichi Nakazawa; Kotaro Kumagai; Tsutomu Tamai; Hiroaki Okamoto; Hirohito Tsubouchi; Akio Ido
Journal:  Hepatol Res       Date:  2014-10-14       Impact factor: 4.288

5.  Surveillance for acute viral hepatitis - United States, 2007.

Authors:  Danni Daniels; Scott Grytdal; Annemarie Wasley
Journal:  MMWR Surveill Summ       Date:  2009-05-22

6.  Hepatitis B birth dose vaccination rates among children in Beijing: A comparison of local residents and first and second generation migrants.

Authors:  Ruohan Chen; Youwei Li; Knut Reidar Wangen; Stephen Nicholas; Elizabeth Maitland; Jian Wang
Journal:  Hum Vaccin Immunother       Date:  2016-04-04       Impact factor: 3.452

7.  Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece.

Authors:  C A Gogos; K P Fouka; G Nikiforidis; K Avgeridis; G Sakellaropoulos; H Bassaris; A Maniatis; A Skoutelis
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

8.  Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose.

Authors:  Maimuna Mendy; Ingrid Peterson; Safayet Hossin; Tom Peto; Momodou L Jobarteh; Adam Jeng-Barry; Mamadi Sidibeh; Abdoulie Jatta; Sophie E Moore; Andrew J Hall; Hilton Whittle
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

9.  Factors associated with intrafamilial transmission of hepatitis B virus infection in Korea.

Authors:  Y S Kim; Y O Ahn
Journal:  J Korean Med Sci       Date:  1993-12       Impact factor: 2.153

10.  A population-based study examining hepatitis B virus infection and immunization rates in Northwest China.

Authors:  Zhaohua Ji; Tingcai Wang; Zhongjun Shao; Dahong Huang; Anhui Wang; Zhiwen Guo; Yong Long; Lei Zhang; Haixia Su; Qi Zhang; Yongping Yan; Daiming Fan
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

View more
  2 in total

1.  Prevalence of hepatitis B virus and associated risk factors among adults patients at Dessie referral and Kemise general hospitals in northeastern Ethiopia.

Authors:  Hussein Mohammed; Aragaw Eshetie; Dessie Melese
Journal:  Health Sci Rep       Date:  2022-05-22

2.  Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China.

Authors:  Chao Wang; Ninghua Huang; Qing-Bin Lu; Steven Black; Xiaofeng Liang; Fuqiang Cui
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.